- ￥2000 - 8000
- 湖北省武汉市
- Xenopus laevis nbl1 重组蛋白表达
- 2025年09月11日
13 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 提供商：
普健生物（武汉）科技有限公司
1. NBL1 Reduces Corneal Fibrosis and Scar Formation after Wounding. [38002252]
2. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. [30442501]
3. Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. [34152804]
4. miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression. [37680006]
5. Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway. [35487890]
2. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. [30442501]
3. Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. [34152804]
4. miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression. [37680006]
5. Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway. [35487890]
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
1. NBL1 Reduces Corneal Fibrosis and Scar Formation after Wounding. [38002252]
2. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. [30442501]
3. Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. [34152804]
4. miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression. [37680006]
5. Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway. [35487890]
2. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. [30442501]
3. Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. [34152804]
4. miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression. [37680006]
5. Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway. [35487890]
技术资料暂无技术资料 索取技术资料
文献支持
Xenopus laevis nbl1 重组蛋白表达
￥2000 - 8000
